<DOC>
	<DOCNO>NCT02418871</DOCNO>
	<brief_summary>The objective study evaluate clinical outcome accommodate intraocular lens ( AIOL ) design provide distance , intermediate , near vision patient undergoing cataract extraction intraocular lens implantation use improve injector system .</brief_summary>
	<brief_title>Evaluation FluidVisionTM AIOL With Improved Injector</brief_title>
	<detailed_description />
	<mesh_term>Presbyopia</mesh_term>
	<criteria>eligible primary intraocular lens implantation correction aphakia follow cataract extraction ; best correct distance visual acuity worse 20/40 either without glare source present ( e.g . Brightness Acuity Tester ) ; predict best correct distance visual acuity 20/30 good cataract removal AIOL implantation determine potential acuity meter ( PAM ) potential vision test surgeon estimation eye ; â‰¤1.0 D preoperative keratometric astigmatism ( first operative eye ) ; clear intraocular medium cataract ; preoperative central endothelial cell density 2200 cells/mm2 ; least 50 year age ; willing able comply schedule followup visit 36 month surgery ; calculate AIOL power within range investigational device ; provide write informed consent . vulnerable population define ISO 14155 ( e.g . individual lack autonomy due mental disability , person nurse home , child ) take medication may affect accommodation ( include limit mydriatic , cycloplegic miotic agent ; tricyclic antidepressant , phenothiazine , benzodiazepine , first generation antihistamine , anticholinergic agent ) systemic disease could increase operative risk confound outcome ( e.g . autoimmune disease , uncontrolled diabetes demonstrate HbA1c value ) ; take systemic medication may confound outcome increase risk subject , i.e . tamsulosin hydrochloride ( Flomax ) medication similar side effect ; ocular condition may predispose future complication ( e.g . anterior segment pathology include glaucoma potentially occludable angle , corneal dystrophy , ocular inflammation ) ; monocular patient presence significant permanent visual function loss fellow eye ; previous intraocular corneal surgery might confound outcome investigation increase risk subject , include implantation multifocal IOL presbyopic corrective surgery fellow eye ; pregnant , lactate course investigation , another condition associate fluctuation hormone could lead refractive change ; diagnose degenerative visual disorder ( e.g. , macular degeneration retinal disorder ) predict cause future best correct distance visual acuity bad 20/30 ; floppy/weak zonule , incomplete zonule zonular rupture cataract extraction ; condition increase risk zonular rupture cataract extraction procedure may affect postoperative centration tilt lens ( e.g. , pseudoexfoliation syndrome ) ; sensitivity plan study medication ; simultaneous participation ophthalmic drug device clinical trial ; intact capsulorhexis posterior capsule time cataract extraction lens implantation ; baseline dilate pupil size &lt; 8mm diameter ; ACD base IOL Master &lt; 2.8 mm ; corneal diameter &lt; 10 mm meridian ; capsulorhexis size &lt; 5.5 mm &gt; 6.0 mm ; within range manufacturer 's fitting algorithm decentered capsulorhexis &gt; 1.0 mm relation limbus ; posterior capsular opacity observe cataract extraction ; complicate cataract surgery prevents attempt implantation AIOL ( e.g . ; pupillary constriction , poor visibility due corneal edema ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>cataract</keyword>
	<keyword>presbyopia</keyword>
</DOC>